Nephros INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
NEPH
Nephros INCNephros, Inc. announced a significant increase in net revenue and net income for the second quarter of 2026, driven by robust product sales and a favorable tariff refund.
NASDAQ
NEPH
Nephros INCNephros, Inc. announced a significant financial turnaround, reporting net income and positive operating cash flow for the third quarter and first nine months of 2025, driven by robust revenue growth.
NASDAQ
NEPH
Nephros INCNephros, Inc. reported a significant increase in net revenue and a return to net income for the second quarter and first half of 2025, driven by strong product sales and improved gross margins.
NASDAQ
NEPH
Nephros INCNephros, Inc. announces a profitable first quarter in 2025, driven by increased net revenue and improved gross margins compared to the same period in 2024.
NASDAQ
NEPH
Nephros INCNephros Inc. experienced a decrease in revenue for the third quarter of 2024, but saw improvements in gross profit margins and a return to profitability.
NASDAQ
NEPH
Nephros INCNephros Inc. experienced a decrease in revenue for the second quarter of 2024, primarily due to reduced emergency response orders, though programmatic sales showed growth.
NASDAQ
NEPH
Nephros INC10-Q: Nephros Inc. Reports First Quarter 2024 Results, Revenue Declines Slightly Amidst Strategic Shifts
Nephros Inc. experienced a slight decrease in revenue for the first quarter of 2024, primarily due to reduced emergency response orders, while programmatic sales saw a 12% increase.